MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma.
Guangbo YuZigeng ZhangAydin EresenQiaoming HouEmilie Elizabeth GarciaZeyang YuNadine Abi-JaoudehVahid YaghmaiZhuoli ZhangPublished in: Journal of translational medicine (2024)
Our study underscored the significant potential of texture-based MRI imaging features in the early assessment of multiple HCC treatment outcomes.